Overview

Efficacy and Safety of TPFinduction Chemotherapy Boundary Resectable Local Advanced Esophageal Squamous Cell Carcinoma

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

Paclitaxel In combination with DDP and 5-FU(TPF) as neoadjuvant chemotherapy in treating boundary resectable locally advanced esophageal squamous cell carcinoma: A phase II clinical trial.

Phase:

Phase 2

Details

Lead Sponsor:

Yuhong Li

Treatments:

Albumin-Bound Paclitaxel
Cisplatin
Fluorouracil
Paclitaxel